You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CDX-301

Showing 26 - 50 of 254
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,

Terminated
  • Advanced Solid Tumor
  • +3 more
  • Darlinghurst, New South Wales, Australia
  • +1 more
Dec 18, 2022

Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, Diffuse Scleroderma Trial in Shanghai (BRL-301)

Recruiting
  • Systemic Lupus Erythematosus (SLE)
  • +5 more
  • BRL-301
  • Shanghai, Shanghai, China
    Shanghai ChangZheng hospital
May 7, 2023

Chronic Inducible Urticaria Trial in United States (barzolvolimab, Matching Placebo)

Recruiting
  • Chronic Inducible Urticaria
  • barzolvolimab
  • Matching Placebo
  • Birmingham, Alabama
  • +31 more
Jan 20, 2023

Head Neck Cancer, Intratumoral Injection Trial in Chicago (RiMO-301)

Recruiting
  • Head Neck Cancer
  • Intratumoral Injection
  • Chicago, Illinois
    University of Illinois at Chicago
Apr 28, 2023

Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major Trial in Nashville (EDIT-301)

Recruiting
  • Transfusion Dependent Beta Thalassemia
  • +3 more
  • EDIT-301
  • Oakland, California
  • +3 more
Jan 3, 2023

Sickle Cell Disease, Hemoglobinopathies Trial in Canada, United States (EDIT-301)

Recruiting
  • Sickle Cell Disease
  • Hemoglobinopathies
  • EDIT-301
  • Oakland, California
  • +18 more
Jan 10, 2023

Parkinson Disease Trial (Gemfibrozil, Placebo)

Not yet recruiting
  • Parkinson Disease
  • (no location specified)
Jun 27, 2023

Perennial Allergic Rhinitis, Rhinitis, Allergic Trial in Mississauga (Treatment A, Treatment B, Treatment C)

Completed
  • Perennial Allergic Rhinitis
  • Rhinitis, Allergic
  • Treatment A
  • +2 more
  • Mississauga, Canada
    Cliantha Research
Apr 6, 2022

Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Worldwide (Camidanlumab Tesirine)

Active, not recruiting
  • Relapsed Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Camidanlumab Tesirine
  • Scottsdale, Arizona
  • +72 more
Dec 15, 2022

Retinitis Pigmentosa Trial (KIO-301)

Recruiting
  • Retinitis Pigmentosa
  • Adelaide, South Australia, Australia
    Royal Adeliade Hospital
Dec 22, 2022

Gastric Cancer Trial in Taiwan (AST-301, rhuGM-CSF)

Not yet recruiting
  • Gastric Cancer
  • Kaohsiung, Taiwan
  • +5 more
Mar 14, 2023

Metastatic Lung Cancer, Metastatic Gastrointestinal Cancer Trial (FoundationOne® Liquid CDx Assay, Standard of Care Diagnostic

Not yet recruiting
  • Metastatic Lung Cancer
  • Metastatic Gastrointestinal Cancer
  • FoundationOne® Liquid CDx Assay
  • Standard of Care Diagnostic Pathway
  • (no location specified)
May 11, 2023

COVID-19 Trial (LMN-301)

Not yet recruiting
  • COVID-19
  • LMN-301
  • (no location specified)
Sep 1, 2023

Non-proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (KSI-301, Sham injection)

Active, not recruiting
  • Non-proliferative Diabetic Retinopathy
  • Phoenix, Arizona
  • +46 more
Sep 22, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in United States (SNS-301, Pembrolizumab)

Terminated
Has Results
  • Squamous Cell Carcinoma of the Head and Neck
  • San Francisco, California
  • +9 more
Dec 6, 2022

Non-muscle Invasive Bladder Cancer, NMIBC, Carcinoma in Situ of Bladder Trial in United States (UGN-301, UGN-201)

Recruiting
  • Non-muscle Invasive Bladder Cancer
  • +5 more
  • Little Rock, Arkansas
  • +7 more
Dec 19, 2022

Wet Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in United States (KSI-301)

Terminated
  • Wet Age-related Macular Degeneration
  • +2 more
  • Phoenix, Arizona
  • +10 more
Nov 1, 2022

Schizophrenia, Schizoaffective Disorder Trial (LYN-005, Risperidone)

Not yet recruiting
  • Schizophrenia
  • Schizoaffective Disorder
  • (no location specified)
Mar 24, 2023

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in United States (Placebo, Inhaled Treprostinil, Treprostinil

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Disease
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +55 more
Aug 16, 2022

Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in China (Mirvetuximab Soravtansine)

Recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • Mirvetuximab Soravtansine
  • Bengbu, Anhui, China
  • +27 more
Nov 14, 2022

Crohn's Disease, IBD Trial in Worldwide (Brazikumab Induction Dose, Brazikumab Maintenance Dose)

Enrolling by invitation
  • Crohn's Disease
  • IBD
  • Brazikumab Induction Dose
  • Brazikumab Maintenance Dose
  • Lincoln, California
  • +116 more
Jan 12, 2023

Chronic Kidney Disease stage4 Trial in United States (US-APR2020)

Recruiting
  • Chronic Kidney Disease stage4
  • KT-301 (formerly US-APR2020)
  • Silver Spring, Maryland
  • +4 more
Oct 11, 2022

Healthy Subjects Trial in Lincoln (CDX-0159, Normal saline)

Completed
  • Healthy Subjects
  • Lincoln, Nebraska
    Celerion, Inc
Jan 20, 2022

NSCLC, Gastric Cancer, Head Neck Cancer Trial (CDX-585)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +13 more
  • (no location specified)
Mar 29, 2023

Diabetic Macular Edema Trial in Latvia, United States (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Diabetic Macular Edema
  • Bakersfield, California
  • +45 more
Jun 2, 2022